GSK

Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

NEW: Price Reaction to Earnings Reports

View detailed tables showing price action before and after earnings announcements, ranging from intraday to one week out. Track how the market has reacted to past earnings to identify patterns and predict future behavior. Click here to open.

Dollar change -0.34
Percentage change -0.93	%

Peers: JNJ PFE MRK BMY LLY NVS AZN ABBV SNY GILD

| Held by: FVD GCOW PPH AVDE FENI RODM DFAX APIE BINV DIHP

Scroll to Statements

Index	-	P/E	22.78	EPS (ttm)	1.58	Insider Own	0.00%	Shs Outstand	2.04B	Perf Week	2.18%
Market Cap	73.55B	Forward P/E	7.85	EPS next Y	4.59	Insider Trans	-	Shs Float	2.04B	Perf Month	5.72%
Income	3.26B	PEG	3.15	EPS next Q	1.02	Inst Own	15.05%	Short Float	0.88%	Perf Quarter	-2.65%
Sales	40.10B	P/S	1.83	EPS this Y	2.80%	Inst Trans	-4.94%	Short Ratio	3.51	Perf Half Y	-8.46%
Book/sh	8.39	P/B	4.30	EPS next Y	12.01%	ROA	4.36%	Short Interest	17.89M	Perf Year	-13.68%
Cash/sh	2.39	P/C	15.09	EPS next 5Y	7.22%	ROE	19.11%	52W Range	31.72 - 45.92	Perf YTD	6.56%
Dividend Est.	1.62 (4.48%)	P/FCF	12.15	EPS past 5Y	-11.63%	ROI	9.20%	52W High	-21.52%	Beta	0.60
Dividend TTM	1.56 (4.33%)	Quick Ratio	0.52	Sales past 5Y	-0.74%	Gross Margin	71.67%	52W Low	13.64%	ATR (14)	0.81
Dividend Ex-Date	Feb 21, 2025	Current Ratio	0.78	EPS Y/Y TTM	-47.11%	Oper. Margin	17.00%	RSI (14)	58.26	Volatility	2.26% 1.60%
Employees	70212	Debt/Eq	1.24	Sales Y/Y TTM	6.28%	Profit Margin	8.13%	Recom	2.65	Target Price	41.27
Option/Short	Yes / Yes	LT Debt/Eq	1.07	EPS Q/Q	21.53%	Payout	94.46%	Rel Volume	1.04	Prev Close	36.38
Sales Surprise	5.94%	EPS Surprise	18.70%	Sales Q/Q	4.14%	Earnings	Feb 05 BMO	Avg Volume	5.09M	Price	36.04
SMA20	4.58%	SMA50	5.14%	SMA200	-7.34%	Trades		Volume	5,316,518	Change	-0.93%

Date	Action	Analyst	Rating Change	Price Target Change
Nov-15-24	Downgrade	Deutsche Bank	Buy → Hold
Nov-12-24	Downgrade	Jefferies	Buy → Hold	$53 → $39.50
Oct-31-24	Downgrade	Guggenheim	Buy → Neutral
Jul-08-24	Downgrade	UBS	Buy → Neutral
May-30-24	Initiated	Goldman	Neutral	$47
Mar-04-24	Upgrade	Guggenheim	Neutral → Buy
Feb-13-24	Upgrade	Citigroup	Neutral → Buy
Jan-23-24	Initiated	Morgan Stanley	Equal-Weight	$44
Jan-16-24	Resumed	UBS	Buy
Jan-03-24	Upgrade	Jefferies	Hold → Buy	$48
Jul-14-23	Initiated	HSBC Securities	Reduce
Mar-17-23	Upgrade	Deutsche Bank	Hold → Buy
Feb-27-23	Resumed	Goldman	Buy
Jan-03-23	Downgrade	JP Morgan	Neutral → Underweight
Dec-05-22	Downgrade	BofA Securities	Neutral → Underperform
Nov-11-22	Downgrade	UBS	Neutral → Sell
Sep-15-22	Upgrade	Credit Suisse	Underperform → Neutral
Sep-08-22	Downgrade	Jefferies	Buy → Hold	$50.50 → $34
Aug-05-22	Resumed	Morgan Stanley	Equal-Weight
Jul-21-22	Resumed	Citigroup	Neutral

Show Previous Ratings

Feb-06-25 07:09AM	Bear Of The Day: GSK PLC (GSK) (Zacks)
02:05AM	GSK PLC (GSK) Q4 2024 Earnings Call Highlights: Strong Specialty Medicines Drive Growth Amid ... (GuruFocus.com)
Feb-05-25 10:42PM	Why GSK plc (GSK) Went Up on Wednesday (Insider Monkey) +8.21%
08:48PM	Analyst Report: GSK plc (Morningstar Research)
04:32PM	GSK Surges 8% After Bumping Its 2031 Outlook To North Of $50 Billion (Investor's Business Daily)
12:05PM	Loading…
12:05PM	GSK Stock Jumps on Long-Term Outlook Boost, $2.5B Share Buyback Plan (Investopedia)
09:59AM	Steady M&A Deals to Begin 2025, Disappointing IPOs So Far (GuruFocus.com)
08:05AM	GSK Q4 Earnings: Revenue And EPS Beat, Initiates $2.5 Billion Stock Buyback, Raises Long-Term Annual Sales Forecast To Over $50 Billion (Benzinga)
07:05AM	GSK (GSK) Tops Q4 Earnings and Revenue Estimates (Zacks)
05:42AM	GSK Lifts Long-Term Outlook on Drug Pipeline, Buys Back Shares (Bloomberg)
02:49AM	GSK FY24 Core Operating Profit Rises, Turnover Up 7% At CER; Increases 2031 Sales Outlook (RTT News)
Feb-04-25 04:13PM	RFK Jr. Clears A Key Hurdle To Head Up HHS. Why His Nomination Is A Biotech Black Box. (Investor's Business Daily)
Jan-29-25 10:01AM	Earnings Preview: GSK (GSK) Q4 Earnings Expected to Decline (Zacks)
08:45AM	GSK announces EMA accepted for review the MAA for depemokimab (TipRanks)
08:00AM	The RFK Jr. Effect: Biotech Stocks Brace For 'Games' In Senate Hearings (Investor's Business Daily)
01:43PM	Loading…
Jan-21-25 01:43PM	Europe Drug Regulator Expands GSK's Jemperli/Chemo Combo To Adult Patients With Advanced Endometrial Cancer (Benzinga)
Jan-20-25 11:29AM	Is GSK plc (GSK) an Undervalued Defensive Stock for 2025? (Insider Monkey)
Jan-18-25 08:20AM	Ozempic, Xtandi among next 15 drugs selected for U.S. price talks (TipRanks)
Jan-17-25 09:46AM	Novo Nordisk's stock down 4% as the Feds get ready for a second round of drug price negotiations (Yahoo Finance)
Jan-16-25 03:23PM	Is GSK plc (GSK) One of the Cheapest Stocks with Biggest Upside Potential? (Insider Monkey)
Jan-13-25 04:06PM	Healthcare M&A poised for a rebound in 2025 (Yahoo Finance Video)
01:57PM	GSK CEO on US Expansion, M&A, Drug Pipeline, Trump (Bloomberg)
12:39PM	GSK CEO on acquisition of biotech firm IDRx (CNBC TV)
11:25AM	Moderna cuts sales forecast on weaker vaccine demand (Yahoo Finance)
02:05AM	GSK Enters Agreement to Acquire IDRx, Inc. (Business Wire)
Jan-06-25 10:37AM	Why Is GSK plc (NYSE:GSK) Among the Best FTSE Dividend Stocks to Buy Now? (Insider Monkey)
Jan-04-25 07:47AM	GSKs Nucala Gains Approval in China for CRSwNP (TipRanks)
Jan-03-25 08:15AM	GSK's Sinus Disease Drug Secures Approval In China (Benzinga)
Dec-26-24 09:00AM	Achievements and Progress Heading into 2025 for Oncology Treatments and Therapies Fuel an Optimistic Outlook (GlobeNewswire)
Dec-18-24 08:45AM	Promising Data for Treating Gastrointestinal Cancer Leading to Hopeful Advancements for Pancreatic and Anal Cancers (GlobeNewswire)
07:35AM	Loading…
Dec-17-24 07:35AM	GSK announces CHMP of the EMA recommended expanding approval of Jemperli (TipRanks)
07:30AM	GSK announces FDA granted BTD for Jemperli (TipRanks)
04:10AM	GSKs lung cancer therapy gains EMA PRIME designation (Pharmaceutical Technology)
Dec-10-24 01:14PM	GSK's Blood Cancer Drug Shows Improved Survival Compared To Johnson & Johnson's Darzalex (Benzinga)
Dec-09-24 01:38PM	Belantamab Mafodotin shows significant overall survival benefit, reducing the risk of death by 42% in multiple myeloma at or after first relapse (Business Wire)
Dec-02-24 07:45AM	Analyst Report: GSK plc (Morningstar Research)
Nov-25-24 10:29AM	GSK gains approval in Japan for extended indication of RSV vaccine (Pharmaceutical Technology)
Nov-23-24 06:40AM	GSK announces Japans MHLW approved application to extend indication of Arexvy (TipRanks)
Nov-19-24 01:24PM	GSK's Investigational Liver Disease Candidate Hits Primary Goal In Late-Stage Study To Treat Relentless Itch In Some Patients (Benzinga)
Nov-18-24 07:30AM	Medicus Pharma Ltd. Appoints Faisal Mehmud, MD, MRCP as Chief Medical Officer (Newsfile)
12:42AM	Analyst Report: GSK plc (Morningstar Research)
Nov-15-24 04:18PM	How analysts are reacting to RFK Jr. as Trump's HHS pick (Yahoo Finance Video)
12:15PM	Stocks to Watch Friday: Applied Materials, Alibaba, Domino's, Novo Nordisk (The Wall Street Journal)
11:15AM	Trumps RFK Jr. Pick Weighs on Vaccine Makers (The Wall Street Journal)
10:46AM	Trump looks to end EV credit, vaccine stocks fall on RFK JR. pick (Yahoo Finance Video)
09:43AM	Analysts think Wall Street's reaction to the RFK Jr. news is 'overdone.' Sort of. (Yahoo Finance)
08:34AM	Heard on the Street: RFK Jr. Is Spooking Obesity Investors Too (The Wall Street Journal)
06:45AM	RFK Jr. News Hits Global Pharma Stocks (The Wall Street Journal)
05:19AM	European Vaccine Makers Under Pressure After Trump Picks RFK Jr to Lead Health Department (The Wall Street Journal)
Nov-14-24 04:28PM	Moderna, Novovax stocks slide after Trump nominates Robert F. Kennedy Jr. to be top health official (Yahoo Finance)
04:28PM	Moderna, Novavax stocks slide after Trump nominates Robert F. Kennedy Jr. to be top health official (Yahoo Finance)
02:50PM	GSK Raises Prospects For Withdrawn Blood Cancer Drug Blenrep To Return To US Market - Here's Why (Benzinga)
Nov-13-24 11:06AM	Regeneron/Sanofi's Dupixent Approval Signals Major Treatment Breakthrough For Smokers' Lung Disease (Benzinga)
09:52AM	Health Canada approves GSKs Ojjaara for myelofibrosis in anaemia patients (Pharmaceutical Technology)
Nov-08-24 09:35AM	Analyst Report: GSK plc (Morningstar Research)
05:00AM	AstraZenecas China-Fueled Plunge May Be Difficult to Shake Off (Bloomberg)
Nov-07-24 04:02PM	Moderna Slashes Hefty Premarket Gain With A Beat That's 'Not A Beat' (Investor's Business Daily)
08:58AM	Moderna Surges After Crushing Sales Forecasts, Reiterating Its Outlook (Investor's Business Daily)
06:30AM	Moderna Posts A Surprise Profit As Sales Wallop Views. But Will RSV Be Its Undoing? (Investor's Business Daily)
Nov-06-24 04:31AM	GSKs RSV vaccine approved in Canada for adults aged 50 to 59 (Pharmaceutical Technology)
Oct-31-24 03:48PM	AstraZeneca Probe in China Adds to Concerns for Foreign Businesses (The Wall Street Journal)
03:04AM	GSK PLC (GSK) Q3 2024 Earnings Call Highlights: Strong Specialty Medicines Growth Amid Vaccine ... (GuruFocus.com)
Oct-30-24 07:31PM	Analyst Report: GSK plc (Morningstar Research)
04:26PM	GSK Plummets To 10-Month Low As RSV, Shingles Vaccines Hit The Skids (Investor's Business Daily)
09:05AM	GSK (GSK) Q3 Earnings Surpass Estimates (Zacks)
09:02AM	GSK Stock Crumbles As Vaccine Sales Plummet And Miss Expectations (Investor's Business Daily)
08:58AM	GSK's Q3 Earnings Hit By Lower Than Expected Vaccine Sales, Cautions Lower Revenue For 2024 (Benzinga)
08:15AM	GSK to acquire CMG1A46 from Chimagen Biosciences (TipRanks)
08:05AM	GSK Stock Drops as UK Firm Posts Underwhelming Results (Investopedia)
07:34AM	GSK Cuts Vaccine Sales Outlook Amid U.S. Weakness (The Wall Street Journal)
05:15AM	GSK to acquire Chimagens CMG1A46 for autoimmune disease (Pharmaceutical Technology)
05:00AM	GlaxoSmithKline Pharmaceuticals Ltd (BOM:500660) Q2 2024 Earnings Call Highlights: Revenue ... (GuruFocus.com)
03:43AM	GSK Profit Rises on HIV, Cancer Treatments But Sales Slip on Weak U.S. Vaccine Demand (The Wall Street Journal)
Oct-28-24 02:12AM	Carmakers Malaise, UBSs Next Step: EMEA Earnings Week Ahead (Bloomberg)
Oct-24-24 04:02PM	Just After Pfizer's RSV Vaccine Approval For Younger Adults, GSK Layouts Encouraging Preliminary Data Showing Potential For Use In Larger Population (Benzinga)
07:00AM	New Data for AREXVY, GSKs Respiratory Syncytial Virus Vaccine, Show Potential to Help Protect a Broader Group of Adults at Increased Risk for RSV Disease (Business Wire)
Oct-23-24 11:31AM	FDA Approves Pfizer's Respiratory Syncytial Virus Vaccine Abrysvo For Adults Below 60 Years (Benzinga)
10:02AM	Analysts Estimate GSK (GSK) to Report a Decline in Earnings: What to Look Out for (Zacks)
Oct-21-24 04:15PM	Korro Bio Is Lagging Wave Life Sciences In RNA Editing. Why It Could Ultimately Lead The Space. (Investor's Business Daily)
Oct-16-24 11:35AM	GSK Seeks FDA Approval For Oral Antibiotic For Urinary Tract Infections, Probably First In New Class In Over 20 Years (Benzinga)
Oct-15-24 10:20AM	GSK sues Moderna for US patent infringement over COVID, RSV vaccines (Reuters)
Oct-14-24 08:43AM	Stocks to Watch Monday: Boeing, SoFi, Sirius XM, MicroStrategy (The Wall Street Journal)
08:39AM	GSK Says Depemokimab For Chronic Rhinosinusitis Reduces Nasal Polyp Size, Nasal Obstruction Versus Placebo At One Year (Benzinga)
Oct-11-24 04:21PM	Jim Cramer Says GSK plc (GSK) Goes Higher (Insider Monkey)
Oct-10-24 02:32PM	Analyst Report: GSK plc (Morningstar Research)
07:47AM	GSK Shares Climb on $2.2 Billion Zantac Lawsuit Settlement (The Wall Street Journal)
06:54AM	GSK Stock Jumps as UK Drug Giant Resolves Most US Zantac Lawsuits (Investopedia)
03:07AM	GSK Rises After Settling Zantac Cases for Up to $2.2 Billion (Bloomberg)
Oct-09-24 06:39PM	Why GSK Stock Rocketed Nearly 6% Skyward on Wednesday (Motley Fool) +5.84%
02:01PM	GSK to Pay Over $2 Billion in Bid to End Most U.S. Zantac Lawsuits (The Wall Street Journal)
01:42PM	GSK Resolves Majority Of US Zantac Cases With $2.2B Settlement Deal, Stock Surges (Benzinga)
Oct-08-24 05:00PM	US Venture Capital Opens Path to Funding for China Biotech Firms (Bloomberg)
07:00AM	GSK Presents Positive Data for AREXVY, Its Respiratory Syncytial Virus (RSV) Vaccine, Indicating Protection Over Three RSV Seasons (Business Wire)
12:04AM	Why Pfizer Will Find It Hard to Appease Its Activist Investor (The Wall Street Journal)
Oct-07-24 01:56PM	Pfizer Wins London Court Battle, GSK's Respiratory Syncytial Virus Vaccine Patents Invalidated (Benzinga)
01:00PM	Starboard Value takes $1 billion stake in Pfizer: Reports (Yahoo Finance)
10:59AM	Low RSV and COVID vaccine usage is in line with investor expectations, but concerning: Jefferies (Yahoo Finance)
10:41AM	Millions urged to delete data from mail-order DNA test maker (The Telegraph)
Oct-04-24 12:31PM	GSK, Sanofi, And CSL Secure US Government Fund To Boost Bird Flu Vaccine Production: Report (Benzinga)
11:26AM	Sanofi, GSK, CSL Tapped to Expand US Bird Flu Vaccine Supply (Bloomberg)

GSK Plc is a healthcare company, which engages in the research, development, and manufacture of pharmaceutical medicines, vaccines, and consumer healthcare products. It operates through the Commercial Operations, and Research and Development segments. The Commercial Operations segment has three product groups of specialty medicines, vaccines, and general medicines. The company was founded in 1715 and is headquartered in Middlesex, the United Kingdom.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
GSK plc	10% Owner	Sep 27 '24	Buy	8.00	2,791,930	22,335,440	16,775,691	Oct 01 05:54 PM

open in yahoo | open in reuters | open in marketwatch | open in google | open in EDGAR

GSK Plc ADR

Upgrade your FINVIZ experience